Genprex Announces U.S. Patent for REQORSA(TM) Immunogene Therapy in Combination with Immune Checkpoint Inhibitors to Treat Cancers

Stock Information for Genprex Inc.

Loading

Please wait while we load your information from QuoteMedia.